Full-Time

Territory Manager

Eye Care

Posted on 5/25/2025

Viatris

Viatris

10,001+ employees

Global pharmaceutical company providing medicines

No salary listed

Mid

Washington, DC, USA

Remote

Must live within geography of responsibility or within reasonable driving distance.

Category
Field Sales
Sales & Account Management
Requirements
  • Minimum of a Bachelor’s degree (or equivalent) and minimum of 2 years of pharmaceutical, medical or related sales experience required with a proven and successful track record in all aspects of technical knowledge, selling techniques, and comprehensive understanding of medical terminology.
  • Must live within geography of responsibility or within reasonable driving distance.
  • Must have valid Driver’s License and acceptable driving record.
  • Ability to travel required. Depending on the territory, overnight travel may be needed.
  • Must meet all access requirements for target offices and health care facilities within assigned territory.
  • Proficiency with Microsoft Office Suite, applicable CRM, and similar databases.
  • Proficiency in speaking, comprehending, reading and writing English is required.
Responsibilities
  • Meets and exceeds corporate sales objectives at the territory level.
  • Develops and maintains strong working partnerships with targeted ECP accounts, and fully represents the vision & culture of Viatris to the Eye Care community.
  • Appropriately leverages expertise of disease state knowledge, the marketplace, and industry and business trends to effectively manage and pull-through business opportunities.
  • Delivers MLR approved, education-focused and patient-centric messages, as well as appropriate disease-state information to target ECP accounts.
  • Achieves business goals on a quarterly & annual basis. Effectively drives territory performance while adhering to compliance and regulatory standards.
  • Works collaboratively with all internal partners to create a positive experience for targeted Eye Care accounts and their patients.
  • Works closely with the field leadership team and internal partners to consistently provide customer insights and offers feedback on strategic initiatives.
  • Demonstrates company culture norms daily through customer interactions, collaboration with internal partners, and a willingness to support others across the organization.
  • Effectively utilizes territory business planning tools to help uncover additional business opportunities.
  • Manages and utilizes approved resources effectively to maximize pull-through on potential and growth opportunities.
  • Complies with all legal, regulatory, and compliance policies while demonstrating a high level of integrity and professionalism at all times.
Desired Qualifications
  • Eye care experience preferred, but not required.

Viatris is a global pharmaceutical company that provides access to a wide range of medicines, including branded and generic drugs, complex generics, and biosimilars. The company operates by leveraging its extensive global commercial infrastructure and supply chain to deliver high-quality medications to patients in over 165 countries. Viatris generates revenue through the sale of its pharmaceutical products, focusing on key therapeutic areas such as cardiovascular health, infectious diseases, immunology, and oncology. What sets Viatris apart from its competitors is its commitment to addressing public health challenges, particularly the increasing prevalence of non-communicable diseases, and its strategy of pursuing both organic growth through its existing products and inorganic growth through strategic partnerships and acquisitions. The company's goal is to improve patient health and ensure sustainable operations in the healthcare sector.

Company Size

10,001+

Company Stage

IPO

Headquarters

Canonsburg, Pennsylvania

Founded

1961

Simplify Jobs

Simplify's Take

What believers are saying

  • Viatris benefits from the growing biosimilars market, projected to grow at 24.7% CAGR.
  • The Asia-Pacific pharmaceutical market's growth offers expansion opportunities for Viatris.
  • Increased demand for cardiovascular drugs aligns with Viatris's key therapeutic areas.

What critics are saying

  • Increased competition in biosimilars could impact Viatris's market share and pricing power.
  • Patent litigation may lead to financial liabilities or loss of market exclusivity.
  • Viatris's significant debt load could limit financial flexibility and growth investments.

What makes Viatris unique

  • Viatris combines generics and branded drugs to address global healthcare needs holistically.
  • The company leverages a unique global supply chain to deliver medicines to 165 countries.
  • Viatris's diverse portfolio includes branded drugs, generics, complex generics, and biosimilars.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Life Insurance

401(k) Retirement Plan

401(k) Company Match

Wellness Program

Paid Holidays

Company News

The Indian Express
Jun 24th, 2025
Biocon's $3.3B Viatris Acquisition Impact

Biocon's acquisition of Viatris for $3.3 billion marks a potential turning point for the company, which has seen muted growth. Despite revenue growth, concerns about debt, equity dilution, and valuation persist. Biocon's business now includes biosimilars, contract research, and generics. The company plans to raise ₹4,500 crore through a Qualified Institutional Placement to reduce its ₹17,756 crore debt. A potential merger with Biocon Biologics Ltd could unlock further value.

PharmiWeb
May 7th, 2025
Viatris Announces Quarterly Dividend

PITTSBURGH, May 7, 2025 /PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS) today announced that on May 5, 2025, its Board of Directors declared a quarterly dividend of $0.12 per share for each issued and outstanding share of the Company's common stock. The dividend is payable on June 16, 2025, to shareholders of record as of the close of business on May 23, 2025.About ViatrisViatris Inc. (Nasdaq: VTRS) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally. With a mission to empower people worldwide to live healthier at every stage of life, we provide access at scale, currently supplying high-quality medicines to approximately 1 billion patients around the world annually and touching all of life's moments, from birth to the end of life, acute conditions to chronic diseases. With our exceptionally extensive and diverse portfolio of medicines, a one-of-a-kind global supply chain designed to reach more people when and where they need them, and the scientific expertise to address some of the world's most enduring health challenges, access takes on deep meaning at Viatris

PR Newswire
Mar 28th, 2025
Viatris To Report First Quarter 2025 Financial Results On May 8, 2025

PITTSBURGH, March 28, 2025 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) will report first quarter 2025 financial results on Thursday, May 8, 2025. Company executives will host a webcast at 8:30 a.m. ET on the same date to discuss the results.Investors and the general public are invited to listen to a live webcast of the call at investor.viatris.com or by calling 844.308.3344 or 412.317.1896 for international callers. A replay of the webcast also will be available on the website.About ViatrisViatris Inc. (NASDAQ: VTRS) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally

PR Newswire
Mar 5th, 2025
Viatris To Present At The Barclays 27Th Annual Global Healthcare Conference

PITTSBURGH, March 5, 2025 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, will present at the Barclays 27th Annual Global Healthcare Conference in Miami Beach, FL on Tuesday, March 11, 2025. The company's fireside chat will begin at 2 p.m. ET.A live webcast of the event at can be found at investor.viatris.com. An archived version of the presentation will be available following the live event and can be accessed at the same location for a limited time.About ViatrisViatris Inc. (NASDAQ: VTRS) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally

INACTIVE